双胎妊娠绒毛膜绒毛取样后的胎儿丢失风险
调整母体及妊娠特征后,CVS未显著增加胎儿丢失风险;未调整时CVS组<24周及孕期任何阶段胎儿丢失风险约增加2倍,该风险主要归因于母体及妊娠特征而非操作本身。
要点
- 双胎CVS后胎儿丢失风险增加约2倍,但调整混杂因素后无显著独立贡献。
- 单绒毛膜性、CRL不一致大及NT增厚是胎儿丢失的独立预测因素。
- CVS组内穿刺针次数和针头大小对胎儿丢失无显著影响。
核心结论
- 双胎妊娠CVS后约2倍的胎儿丢失风险在很大程度上可由母体及妊娠特征解释,而非侵入性操作本身。
研究设计与样本
- 多中心前瞻性研究,纳入8个胎儿医学单位11-13周双胎妊娠8581例,其中316例双绒毛膜和129例单绒毛膜双胎接受CVS。
主要发现
- 与未行CVS的双胎相比,CVS组<24周胎儿丢失及孕期任何阶段丢失风险约增加2倍。
- 预测流产或胎儿丢失的独立因素包括母体体重增加、黑人种族、单绒毛膜性(尤其单羊膜囊性)、CRL不一致大及NT增厚;任何阶段胎儿丢失还受辅助受孕和低PAPP-A影响。
- 调整母体及妊娠特征后,CVS对胎儿丢失风险无显著贡献。
- CVS组内穿刺针次数和针头大小对胎儿丢失无显著贡献。
临床怎么用
- 咨询双胎CVS时,应告知胎儿丢失风险主要与母体及妊娠特征相关,而非操作本身。
- 对单绒毛膜性、CRL不一致大或NT增厚的双胎,应充分评估胎儿丢失风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the chorionic villus sampling (CVS)-related risk of fetal loss in twin pregnancy after adjustment for chorionicity, nuchal translucency thickness (NT), intertwin discordance in crown-rump length (CRL), maternal demographic characteristics and serum pregnancy-associated plasma protein-A (PAPP-A) and free β-human chorionic gonadotropin (β-hCG). METHODS: This was a multicenter study from eight fetal medicine units in which the leadership were trained at the Harris Birthright Research Centre for Fetal Medicine in London, UK, and in which the protocols for screening, invasive testing and pregnancy management are similar. Data were obtained prospectively from women with twin pregnancy undergoing routine ultrasound examination at 11-13 weeks' gestation. Multivariable logistic regression analysis with backward stepwise elimination was used to examine whether CVS provided a significant independent contribution to the prediction of risk of fetal loss after adjusting for maternal and pregnancy characteristics, including maternal age, racial origin and weight, method of conception, smoking status, parity, chorionicity, intertwin discordance in CRL, fetal NT ≥ 95th percentile and free β-hCG and PAPP-A multiples of the median. Similarly, within the CVS group, multivariable logistic regression analysis was used to investigate the effect of the number of intrauterine needle insertions and size of the needle on the risk of fetal loss. RESULTS: The study population of 8581 twin pregnancies undergoing ultrasound examination at 11-13 weeks' gestation included 316 dichorionic and 129 monochorionic twins that had CVS. First, in twin pregnancies undergoing CVS, compared to those not undergoing CVS, there was a 2-fold increased risk of fetal loss at < 24 weeks' gestation and of loss at any stage in pregnancy. Second, the factors providing a significant independent contribution to the prediction of miscarriage or fetal loss in twin pregnancy were increased maternal weight, black racial origin, monochorionicity, and more so monoamnionicity, large intertwin discordance in CRL and increased fetal NT, and, in the case of fetal loss at any stage, there was also a contribution from assisted conception and low serum PAPP-A. Third, after adjustment for maternal and pregnancy characteristics, CVS did not provide a significant contribution to the risk of fetal loss. Fourth, in twin pregnancies that had CVS, there was no significant contribution to fetal loss from the number of intrauterine needle insertions or needle size. CONCLUSION: The 2-fold increased risk of fetal loss following CVS in twin pregnancy can, to a great extent, be explained by maternal and pregnancy characteristics rather than the invasive procedure itself. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Elger T, Akolekar R, Syngelaki A, et al. Fetal loss after chorionic villus sampling in twin pregnancy. Ultrasound Obstet Gynecol. 2021. PMID: 34038977. doi:10.1002/uog.23694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。